161 research outputs found

    Changing ideas about others' intentions: updating prior expectations tunes activity in the human motor system

    Get PDF
    Predicting intentions from observing another agent’s behaviours is often thought to depend on motor resonance – i.e., the motor system’s response to a perceived movement by the activation of its stored motor counterpart, but observers might also rely on prior expectations, especially when actions take place in perceptually uncertain situations. Here we assessed motor resonance during an action prediction task using transcranial magnetic stimulation to probe corticospinal excitability (CSE) and report that experimentally-induced updates in observers’ prior expectations modulate CSE when predictions are made under situations of perceptual uncertainty. We show that prior expectations are updated on the basis of both biomechanical and probabilistic prior information and that the magnitude of the CSE modulation observed across participants is explained by the magnitude of change in their prior expectations. These findings provide the first evidence that when observers predict others’ intentions, motor resonance mechanisms adapt to changes in their prior expectations. We propose that this adaptive adjustment might reflect a regulatory control mechanism that shares some similarities with that observed during action selection. Such a mechanism could help arbitrate the competition between biomechanical and probabilistic prior information when appropriate for prediction

    Quantum numbers of the X(3872)X(3872) state and orbital angular momentum in its ρ0Jψ\rho^0 J\psi decay

    Get PDF
    Angular correlations in B+X(3872)K+B^+\to X(3872) K^+ decays, with X(3872)ρ0J/ψX(3872)\to \rho^0 J/\psi, ρ0π+π\rho^0\to\pi^+\pi^- and J/ψμ+μJ/\psi \to\mu^+\mu^-, are used to measure orbital angular momentum contributions and to determine the JPCJ^{PC} value of the X(3872)X(3872) meson. The data correspond to an integrated luminosity of 3.0 fb1^{-1} of proton-proton collisions collected with the LHCb detector. This determination, for the first time performed without assuming a value for the orbital angular momentum, confirms the quantum numbers to be JPC=1++J^{PC}=1^{++}. The X(3872)X(3872) is found to decay predominantly through S wave and an upper limit of 4%4\% at 95%95\% C.L. is set on the fraction of D wave.Comment: 16 pages, 4 figure

    Comparative LCA of concrete with recycled aggregates: a circular economy mindset in Europe

    Full text link
    [EN] Purpose Construction and demolition waste (C&DW) is the largest waste stream in the European Union (EU) and all over the world. Proper management of C&DW and recycled materials¿including the correct handling of hazardous waste¿can have major benefits in terms of sustainability and the quality of life. The Waste Framework Directive 2008/98/EC aims to have 70% of C&DW recycled by 2020. However, except for a few EU countries, only about 50% of C&DW is currently being recycled. In the present research, the environmental impact of concrete with recycled aggregates and with geopolymer mixtures is analysed. The aim of the present research is to propose a comparative LCA of concrete with recycled aggregates in the context of European politics. Methods Life cycle assessment (LCA) methodology is applied using Simapro© software. A cradle to grave analysis is carried out. The results are analysed based on the database Ecoinvent 3.3 and Impact 2002+. Results Results show that the concrete with 25% recycled aggregates is the best solution from an environmental point of view. Furthermore, geopolymer mixtures could be a valid alternative to reduce the phenomenon of ¿global warming¿; however, the production of sodium silicate and sodium hydroxide has a great environmental impact. Conclusions A possible future implementation of the present study is certainly to carry out an overall assessment and to determine the most cost-effective option among the different competing alternatives through the life cycle cost analysis.Colangelo, F.; Gómez-Navarro, T.; Farina, I.; Petrillo, A. (2020). Comparative LCA of concrete with recycled aggregates: a circular economy mindset in Europe. International Journal of Life Cycle Assessment. 25(9):1790-1804. https://doi.org/10.1007/s11367-020-01798-6S17901804259Akhtar A, Sarmah (2018) Construction and demolition waste generation and properties of recycled aggregate concrete: a global perspective. J Cleaner Prod 186:262–281Bare JC, Hofstetter P, Penningtonne DW, Helias A, de Haes U (2000) Midpoints versus endpoints: the sacrifices and benefits. Int J Life Cycle Assess 5(6):319–326Blengini GA, Garbarino E (2010) Resources and waste management in Turin (Italy): the role of recycled aggregates in the sustainable supply mix. J Clean Prod 18(10–11):1021–1030Blengini GA, Garbarino E, Šolar S, Shields DJ, Hámor T, Vinai R, Agioutantis Z (2012) Life cycle assessment guidelines for the sustainable production and recycling of aggregates: the sustainable aggregates resource management project (SARMa). J Clean Prod 27:177–181Blengini GA, Garbarino E, Bevilacqua P (2017) Sustainability and integration between mineral resources and C&DW management: overview of key issues towards a resource-efficient Europe. Env Eng Man J 16(2):493–502Borghi G, Pantini S, Rigamonti L (2018) Life cycle assessment of non-hazardous construction and demolition waste (CDW) management in Lombardy region (Italy). J Clean Prod 184:815–825Braga AM, Silvestre JD, de Brito J (2017) Compared environmental and economic impact from cradle to gate of concrete with natural and recycled coarse aggregates. J Clean Prod 162:529–543Chen C, Habert G, Bouzidi Y, Jullien A, Ventura A (2010) LCA allocation procedure used as an incitative method for waste recycling: an application to mineral additions in concrete. Res Con Rec 54(12):1231–1240Chen Z, Gu H, Bergman RD, Liang S (2020) Comparative life-cycle assessment of a high-rise mass timber building with an equivalent reinforced concrete alternative using the Athena impact estimator for buildings. Sustainability (Switzerland) 12(11):4708Colangelo F, Cioffi R (2017) Mechanical properties and durability of mortar containing fine fraction of demolition wastes produced by selective demolition in South Italy. Comp Part B: Eng 115:43–50Colangelo F, Petrillo A, Cioffi R, Borrelli C, Forcina A (2018a) Life cycle assessment of recycled concretes: a case study in southern Italy. Sci Total Env 615:1506–1517Colangelo F, Forcina A, Farina I, Petrillo A (2018b) Life cycle assessment (LCA) of different kinds of concrete containing waste for sustainable construction. Buildings 8(5):70Colangelo F, Navarro TG, Petrillo A, Farina I, Cioffi R (2020) Life-cycle impact of concrete with recycled materials. Encyclopedia of Renewable and Sustainable Materials, Volume 5(2020):414–421COM (2012) 433, COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Strategy for the sustainable competitiveness of the construction sector and its enterprises, http://eur-lex.europa.eu/procedure/EN/201859, Brussels, 31.7.2012, COM(2012) 433 finalCOM (2014) 445, COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL, http://ec.europa.eu/environment/eussd/pdf/SustainableBuildingsCommunication.pdf, Brussels, 1.7.2014 COM(2014) 445 finalDavidovits J (2018) Geopolymers based on natural and synthetic metakaolin a critical review. Ceramic Eng Science Proc 38(3):201–214Di Maria A, Eyckmans J, Van Acker K (2018) Downcycling versus recycling of construction and demolition waste: combining LCA and LCC to support sustainable policy making. Waste Man 75:3–21Directive 2008/98/EC on waste (Waste Framework Directive), http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32008L0098EN 1992-1-1:(2004) Eurocode 2: Design of concrete structures - Part 1–1: General rules and rules for buildingsEstanqueiro B, Dinis Silvestre J, de Brito J, Duarte Pinheiro M (2018) Environmental life cycle assessment of coarse natural and recycled aggregates for concrete. Eur J Env Civ Eng 22(4):429–449Etxeberria M, Vázquez E, Marí A, Barra M (2007) Influence of amount of recycled coarse aggregates and production process on properties of recycled aggregate concrete. Cem Conc Res 37(5):735–742EU construction & demolition waste management protocol (2016) BrusselsGálvez-Martos J-L, Styles D, Schoenberger H, Zeschmar-Lahl B (2018) Construction and demolition waste best management practice in Europe. Res Con Rec 136:166–178Gluth, G.J.G., Arbi, K., Bernal, S.A., Bondar, D., Castel, A., Chithiraputhiran, S., Dehghan, A., Dombrowski-Daube, K., Dubey, A., Ducman, V., Peterson, K., Pipilikaki, P., Valcke, S.L.A., Ye, G., Hajimohammadi, A., van Deventer, J.S.J., 2017. Characterisation of one-part geopolymer binders made from fly ash. Waste Biom Val, 8(1), pp. 225–233Gomes R, Silvestre JD, de Brito J (2020) Environmental, economic and energy life cycle assessment “from cradle to cradle” (3E-C2C) of flat roofs. Journal of Building Engineering 32:101436ISO 14040 (2006) Environmental management life cycle assessment. Principles and Framework. ISO, GenevaISO 14044 (2006) Environmental management. Life cycle assessment. Requirements and Guidelines. ISO, GenevaJafary Nasab T, Monavari SM, Jozi SA, Majedi H (2020) Assessment of carbon footprint in the construction phase of high-rise constructions in Tehran. Int J Environ Sci Technol 17(6):3153–3164Jolliet O, Margni M, Charles R, Humbert S, Payet J, Rebitzer G, Rosenbaum R (2003) Impact 2002+: a new life cycle impact assessment methodology. Int J Life Cycle Assess 8(6):324–333Khan MW, Ali Y, De Felice F, Salman A, Petrillo A (2019) Impact of brick kilns industry on environment and human health in Pakistan. Sci Total Environ 678:383–389Knoeri C, Sanyé-Mengual E, Althaus H-J (2013) Comparative LCA of recycled and conventional concrete for structural applications. Int J Life Cycle Assess 18(5):909–918Lu W, Yan H (2011) A framework for understanding waste management studies in construction. Waste Man 31:1252–1260Marinković S, Radonjanin V, Malešev M, Ignjatović I (2010) Comparative environmental assessment of natural and recycled aggregate concrete. Waste Man 30(11):2255–2264Mercante IT, Bovea MD, Ibáñez-Forés V, Arena AP (2012) Life cycle assessment of construction and demolition waste management systems: a Spanish case study. Int J Life Cycle Assess 17(2):232–241Pantini S, Giurato M, Rigamonti L (2019) A LCA study to investigate resource-efficient strategies for managing post-consumer gypsum waste in Lombardy region (Italy). Res Con Rec 147:157–168Petrillo A, Cioffi R, De Felice F, Colangelo F, Borrelli C (2016) An environmental evaluation: a comparison between geopolymer and OPC concrete paving blocks manufacturing process in Italy. Env Prog Sus Energy 35(6):1699–1708Provis JL (2017) Alkali-activated cementitious materials and concretes - steps towards standardization, American Concrete Inst, ACI Special Publication 2017-January (SP 320), pp. 444-448Sayagh S, Ventura A, Hoang T, François D (2010) Sensitivity of the LCA allocation procedure for BFS recycled into pavement structures. Res cons rec 54(6):348–358Tangtinthai N, Heidrich O, Manning DAC (2019) Role of policy in managing mined resources for construction in Europe and emerging economies. J Env Man 236:613–621Tošić N, Marinković S, Dašić T, Stanić M (2015) Multicriteria optimization of natural and recycled aggregate concrete for structural use. J Clean Prod 87(1):766–776Van den Heede P, De Belie N (2012) Environmental impact and life cycle assessment (LCA) of traditional and ‘green’ concretes: literature review and theoretical calculations. Cem Conc Comp 34(4):431–442Vossberg C, Mason-Jones K, Cohen B (2014) An energetic life cycle assessment of C&D waste and container glass recycling in Cape Town, South Africa. Res Con Rec 88:39–49Walling SA, Notman S, Watts P, Govan N, Provis JL (2019) Portland cement based immobilization/destruction of chemical weapon agent degradation products. Industrial Eng Chemistry Res 58(24):10383–10393Wu H, Zuo J, Yuan H, Zillante G, Wang J (2019) A review of performance assessment methods for construction and demolition waste management. Res Cons Recycling 150:104407Zhang C, Hu M, Dong L, Gebremariam A, Mirand-Xicotencatl B, Di Maio F, Tukker A (2019) Eco-efficiency assessment of technological innovations in high-grade concrete recycling. Res Cons Recycling 149:649–66

    May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

    Get PDF
    Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. Methods and results Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. Conclusion May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk

    Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

    Get PDF
    Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population

    Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

    Get PDF
    Background: Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies. Methods: For this cross-sectional study, we assessed children and adolescents younger than 18 years with a clinical or genetic diagnosis of HeFH at the time of entry into the Familial Hypercholesterolaemia Studies Collaboration (FHSC) registry between Oct 1, 2015, and Jan 31, 2021. Data in the registry were collected from 55 regional or national registries in 48 countries. Diagnoses relying on self-reported history of familial hypercholesterolaemia and suspected secondary hypercholesterolaemia were excluded from the registry; people with untreated LDL cholesterol (LDL-C) of at least 13·0 mmol/L were excluded from this study. Data were assessed overall and by WHO region, World Bank country income status, age, diagnostic criteria, and index-case status. The main outcome of this study was to assess current identification and management of children and adolescents with familial hypercholesterolaemia. Findings: Of 63 093 individuals in the FHSC registry, 11 848 (18·8%) were children or adolescents younger than 18 years with HeFH and were included in this study; 5756 (50·2%) of 11 476 included individuals were female and 5720 (49·8%) were male. Sex data were missing for 372 (3·1%) of 11 848 individuals. Median age at registry entry was 9·6 years (IQR 5·8-13·2). 10 099 (89·9%) of 11 235 included individuals had a final genetically confirmed diagnosis of familial hypercholesterolaemia and 1136 (10·1%) had a clinical diagnosis. Genetically confirmed diagnosis data or clinical diagnosis data were missing for 613 (5·2%) of 11 848 individuals. Genetic diagnosis was more common in children and adolescents from high-income countries (9427 [92·4%] of 10 202) than in children and adolescents from non-high-income countries (199 [48·0%] of 415). 3414 (31·6%) of 10 804 children or adolescents were index cases. Familial-hypercholesterolaemia-related physical signs, cardiovascular risk factors, and cardiovascular disease were uncommon, but were more common in non-high-income countries. 7557 (72·4%) of 10 428 included children or adolescents were not taking lipid-lowering medication (LLM) and had a median LDL-C of 5·00 mmol/L (IQR 4·05-6·08). Compared with genetic diagnosis, the use of unadapted clinical criteria intended for use in adults and reliant on more extreme phenotypes could result in 50-75% of children and adolescents with familial hypercholesterolaemia not being identified. Interpretation: Clinical characteristics observed in adults with familial hypercholesterolaemia are uncommon in children and adolescents with familial hypercholesterolaemia, hence detection in this age group relies on measurement of LDL-C and genetic confirmation. Where genetic testing is unavailable, increased availability and use of LDL-C measurements in the first few years of life could help reduce the current gap between prevalence and detection, enabling increased use of combination LLM to reach recommended LDL-C targets early in life

    Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

    Get PDF
    PURPOSE: As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19-free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS: This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19-free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS: Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19-free surgical pathways. Patients who underwent surgery within COVID-19-free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19-free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score-matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19-free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION: Within available resources, dedicated COVID-19-free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

    Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study

    Get PDF
    PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks

    The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

    Get PDF
    AIM: The SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery. METHODS: This was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4 weeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin. RESULTS: Overall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4 weeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, P = 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, P < 0.001). After adjustment, delay was not associated with a lower rate of complete resection (OR 1.18, 95% CI 0.90-1.55, P = 0.224), which was consistent in elective patients only (OR 0.94, 95% CI 0.69-1.27, P = 0.672). Longer delays were not associated with poorer outcomes. CONCLUSION: One in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease
    corecore